An analysis of the HumaPen Luxura HD pen: what is the role of 0.5-unit insulin dosing?
The HumaPen Luxura HD is an insulin pen device that has the ability to deliver insulin in half-unit increments. This study demonstrates the precision of this pen device using a computer-controlled dose accuracy glide force system. Although one other half-unit pen device is currently on the market, w...
Saved in:
Published in | Journal of diabetes science and technology Vol. 4; no. 2; pp. 357 - 358 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United States
Diabetes Technology Society
01.03.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The HumaPen Luxura HD is an insulin pen device that has the ability to deliver insulin in half-unit increments. This study demonstrates the precision of this pen device using a computer-controlled dose accuracy glide force system. Although one other half-unit pen device is currently on the market, we are not aware of any studies using a similar methodology to verify its precision and accuracy. Clinical experience in treating a select group of adults with diabetes demonstrates the need for such a device. Although there are no outcome studies, this device should help to improve glycemic control and reduce hypoglycemia in such patients. We believe a half-unit insulin pen device is beneficial to more than just the pediatric population, and therefore, this device represents an improvement in present technology. |
---|---|
Bibliography: | Disclosures: Dr. Magnotti is on the speaker's bureau of Novo Nordisk and Eli Lilly. Dr. Rayfield is on the speaker's bureau of Amylin, Eli Lilly, Glaxo Smith Kline, Merck, Novartis, Novo Nordisk, and sanofi aventis. |
ISSN: | 1932-2968 1932-3107 |
DOI: | 10.1177/193229681000400217 |